The story
The company was originally listed on the Oslo Stock Exchange as Carasent ASA. In 2024, a merger was carried out in which Carasent AB became the acquiring company, and the share listing was transferred to Nasdaq Stockholm.[2]
Since 2018, Carasent has completed several acquisitions, including Evimeria AB (2018), Avans Soma (2020) [3], Metodika (2021), Medrave (2022), Health Profile Institute (2022), and the German electronic health record provider Data-AL GmbH (2024).
From Wikipedia’s article on Carasent, shared under CC BY-SA 4.0.5
